Datasheet

Enterococcus faecium; 1.551 (CAT#: LBST-098FG)

Enterococcus faecium is a Gram-positive bacterium. It can be commensal in the gastrointestinal tract of humans and animals.

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

CAT Size Price Quantity  
LBST-098FG
Product Information
Product Overview Enterococcus faecium is a Gram-positive bacterium. It can be commensal in the gastrointestinal tract of humans and animals.
Target Enterococcus
Genus Enterococcus
Strain Designation 1.551
Application Study and research
Type Strain No
Culture Medium BHI
Culture Conditions 28°C; Aerobiotic
Characteristics The thalli were spherical, arranged in pairs or piles, and gram-positive.
Risk Group 1
Product Format Freeze-dried
Packaging Ampoule tube
Storage -80°C
Shelf Life 6 years
Target Introduction
Introduction Enterococcus are lactic acid bacteria; LAB comprising both pathogenic and commensal microorganisms ubiquitous in environment even as gut symbionts. They are extensively studied as potential candidate probiotics. Several number of Enterococcus strains have been reported to produce antimicrobial compounds including bacteriocins. Bacteriocin production have be applied to preservation of a wide range of food products and is now being considered as a probiotic trait. Besides, bacteriocins are considered as promising alternative to fight emerging antimicrobial resistance. Enterococcus probiotics can be used in treatment and/or prevention of certain human and animal diseases such as alleviation of irritable bowel syndrome symptoms and antibiotic-induced diarrhea and prevention of different functional and chronic intestinal diseases. Moreover, some Enterococcus exhibit anticarcinogenic, hypocholesterolemic, as well as immune regulation effects.
Alternative Names Enterococcus faecium; 1.551
FAQs Customer Reviews Related Products
  1. How can Enterococcus faecium; 1.551 be administered in in vitro experiments?

    In in vitro experiments, Enterococcus faecium; 1.551 can be added directly to cell cultures at a concentration determined by preliminary dose-response studies. It is important to consider the MOI (Multiplicity of Infection) and the specific requirements of the cell lines used.

  2. What is the best method for long-term storage of Enterococcus faecium; 1.551?

    For long-term storage, Enterococcus faecium; 1.551 should be stored in cryoprotectant such as 15% glycerol at -80°C. This method helps preserve the viability and genetic integrity of the bacteria for extended periods.

  3. How can Enterococcus faecium; 1.551 be quantified in a sample?

    Enterococcus faecium; 1.551 can be quantified using plate count methods, quantitative PCR, or flow cytometry. These techniques allow accurate measurement of bacterial concentration in different samples, facilitating research on its growth and effects.

  4. How can the growth curve of Enterococcus faecium; 1.551 be monitored?

    The growth curve can be monitored by measuring optical density at 600 nm (OD600) at regular intervals. This helps in understanding the lag, log, stationary, and death phases of bacterial growth under specific experimental conditions.

  5. What methods are available for extracting DNA from Enterococcus faecium; 1.551?

    DNA extraction can be performed using commercial kits designed for Gram-positive bacteria, involving enzymatic lysis, protein precipitation, and DNA purification steps. Ensuring complete cell lysis is crucial for high-quality DNA.

  • Superior Strain for Microbiome Research
    Enterococcus faecium; 1.551 from Creative Biolabs enhanced my microbiome research with its stability and high viability. Its performance is far superior to other products in the market.
  • Superior Stability in Probiotic Formulations
    Enterococcus faecium; 1.551 demonstrated superior stability in probiotic formulations, greatly enhancing my research outcomes. Creative Biolabs provides top-notch quality.
  • Enhanced Performance in Immunology Research
    The Enterococcus faecium; 1.551 strain from Creative Biolabs showed enhanced performance in immunology research. Its high viability and effectiveness are unmatched.
  • Optimal for Pathogen Inhibition Studies
    Enterococcus faecium; 1.551 offered by Creative Biolabs showed optimal results in pathogen inhibition studies. Its stability and high efficacy are commendable.
  • Robustness in Biotherapeutic Research
    The Enterococcus faecium; 1.551 strain from Creative Biolabs exhibited excellent robustness in biotherapeutic research. Its superior performance and high viability make it a standout product.

Click the button below to contact us or submit your feedback about this product.


Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Live Biotherapeutic

Contact us

Copyright © 2024 Creative Biolabs. All Rights Reserved.

Inquiry Basket